Đang chuẩn bị liên kết để tải về tài liệu:
Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: A retrospective, multicenter study
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The purpose of this study was to compare clinical outcomes of Erlotinib versus Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma and newly diagnosed brain metastases. |